Urine Collection Devices Market - By Product Type, By Patient, By Application, By End Use - Global Forecast, 2025 - 2034

Urine Collection Devices Market Size

The global urine collection devices market was valued at USD 4.6 billion in 2024. The market is expected to reach from USD 4.8 billion in 2025 to USD 8.4 billion in 2034, growing at a CAGR of 6.5% during the forecast period. The high market growth is attributed to the rising prevalence of chronic kidney disorders and UTIs, growing aging population with increasing incidence of incontinence, expansion of home healthcare and point-of-care testing, and ongoing technological advancements in product design, among other contributing factors.

Urine collection devices are designed to collect, store, and in some cases, transport urine samples for diagnostic testing. These tools include specimen bags, collection kits, sample cups, containers, and related accessories. They are widely used across hospitals, laboratories, and home care settings for applications such as clinical urinalysis, drug screening, and pregnancy testing. The design of these devices ensures safe and accurate sample collection and handling.
 

Leading players in the urine collection devices market include Becton, Dickinson and Company, Medline, Abbott, Roche, and Thermo Fisher Scientific. These companies maintain their competitive edge through continuous product innovation, global market presence, and significant investments in research and development.
 

The market has increased from USD 4 billion in 2021 and reached USD 4.4 billion in 2023, with the historic growth rate of 5.1%. The market growth was driven by the rising clinical studies in nephrology, oncology, and metabolic disorders which require urine sample collection for biomarker and genomic analysis. As a result, the demand for specialized urine collection kits compatible with laboratory and molecular research workflows has been positively impacted.
 

The increasing incidence of urinary tract infections (UTIs), kidney disorders, and renal complications is driving demand for urine collection devices, including specimen bags and containers. For instance, according to the Centers for Disease Control and Prevention (CDC) in 2023, UTIs accounted for approximately 8.1 million healthcare visits annually in the U.S. The National Institute of Diabetes and Digestive and Kidney Diseases, in 2022, reported that about 37 million Americans (15% of adults) had chronic kidney disease. Further, The World Health Organization (WHO) report , in 2024, indicated  a 9.1% global increase in the prevalence of kidney disease between 2021 and 2023. Urine collection devices serve as vital tools in clinical settings, facilitating timely diagnosis and effective monitoring of a wide range of conditions, thereby improving patient care and clinical outcomes.
 

Moreover, the healthcare industry is experiencing a transition toward home-based diagnostics and long-term care, especially for patients managing chronic conditions or mobility limitations. According to the Centers for Medicare & Medicaid Services (CMS), home health spending in the U.S. rose from USD 125.2 billion in 2021 to USD 134.7 billion in 2022. The National Center for Health Statistics in 2023, reported that 66% of adults over the age of 65 were managing one or more chronic conditions. This shift has created a rising need for urine collection kits, collection cups, and pediatric urine specimen bags that enhance patient compliance, comfort and ease of use in home care settings.
 

Urine Collection Devices Market Trends

The market is witnessing significant growth, driven by the increase in self-testing systems and home-based diagnostics, surge in the urine-based genomic and biomarker tests, advancements in specimen containers & kits, and integration of digital tracking systems and barcoding solutions, among other factors are collectively boosting the industry growth.
 

• There is a growing demand for urine collection kits and containers that enable sample collection outside clinical settings. This trend is driven by rising patient preference for convenience, remote diagnostics, and expansion of telehealth services. Manufacturers are providing easy-to-use, pre-labeled, and courier-compatible kits for tests such as drug screening, pregnancy detection, and monitoring for several chronic diseases.
   
• Additionally, the use of urine as a non-invasive biofluid for molecular diagnostics including cancer biomarker detection and liquid biopsy is increasing. According to the National Cancer Institute (NCI), urine-based liquid biopsy tests increased by 45% between 2021 and 2023. This motivates the creation of urine collection devices equipped with stabilizers and DNA/RNA preservative media. The number of urine-based diagnostic tests rose from 7 to 12 between 2021 and 2023. Companies like QIAGEN, Roche and other market leaders are advancing research grade collection solutions.
   
• Technological advancements in container design include ergonomic shapes, integrated temperature strips, pre-attached preservatives, and tamper-evident lids. These improvements enhance ease of use, support automation with lab equipment, and strengthen sample security and handling ergonomics. As a result, hospitals, research institutions, and diagnostic labs are achieving greater operational efficiency and improved sample integrity.
   
• Further, the market is witnessing increased availability of pediatric-specific urine specimen bags that minimize discomfort and risk of contamination. These are especially relevant for neonatal and pediatric diagnostic use in hospitals and home settings. Lightweight, hypoallergenic adhesives and non-invasive bag designs are improving the accuracy of urine collection in infants and toddlers. Thus, the aforementioned factors are expected to drive the market growth positively.
   

Urine Collection Devices Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

The global market was valued at USD 4 billion in 2021. The market size reached USD 4.4 billion in 2023, from USD 4.2 billion in 2022.
 

Based on the product type, the market is segmented into urine collection kits, urine specimen bags, and urine cups & containers. The urine collection kits segment has asserted its dominance in the market by securing a significant market share of 69.4% in 2024 owing to the growing need for At-home collection kits, rising adoption in decentralized clinical trials and research, and surging emphasis on sterility, safety, and sample integrity. The segment is expected to exceed USD 5.7 billion by 2034, growing at a CAGR of 6.4% during the forecast period. On the other hand, urine specimen bags segment is expected to grow with a CAGR of 7.1%. The growth of this segment can be attributed to the rising demand in pediatric and neonatal care, advancements in bag materials and sustainability, and expansion in home healthcare and chronic care.
 

• The urine collection kits segment continues to dominate the market. Urine collection kits designed for home use are gaining popularity due to rising demand for convenience and remote diagnostics. These kits are on the rise for drug screening, pregnancy testing, and chronic disease monitoring. There is a growing market for pre-packaged, user-friendly kits which come with detailed instructions allowing sample collection without requiring clinical guidance.
   
• Urine collection kits are becoming increasingly specialized based on their application whether for drug screening, urinalysis, or genetic testing. The kits are supplied with labels, preservatives, and collection instruments that are specially designed for the labelled purpose as well as suitable transport packaging. This tailoring is enhancing the accuracy and efficiency while eliminating processing errors in laboratories and hospitals.
   
• The market shows increasing development of specialized urine collection kits designed for children and elderly patients. According to the U.S. Census Bureau, the population aged 65 and older increased by 38.2% between 2021 and 2023, reaching 57.3 million. Additionally, the Centers for Medicare & Medicaid Services, in 2022, showed a rise in Home Health Care (HHC) expenditure by 6.7%, amounting to USD 125.6 billion. This indicates a growing potential for home medical ancillary services.
   
• These products also have pediatric adhesive bags, ergonomic containers, and collection aids to help maintain standards of hygiene to increase comfort for the patients. According to National Center for Health Statistics, there was a 15.3% increase in outpatient visits from 2021 to 2023, which is anticipated to drive the growth of specialized collection kits for use in home healthcare and outpatient facilities.This is driving the expansion of home healthcare and outpatient facilities collection kits.
   
• The urine specimen bags segment is expected to grow the fastest over the forecast period. Hospitals and nursing homes are now using closed-system urine specimen bags more frequently because they reduce the risk of catheter-associated urinary tract infections (CAUTIs). These systems help prevent external contamination and enable safer transport of samples. To enhance clinical effectiveness and hygiene, manufacturers are adding anti-reflux valves and sampling ports. This is noticeable in older care centers, surgical wards, and ICUs.
   
• Additionally, there is a rise in the development of softer adhesives and anatomically shaped specimen bags for infants, as well as pediatric-friendly designs. These bags are tailored to the needs of younger patients who are unwilling or unable to provide urine samples. There is increasing demand in pediatric hospitals, as well as outpatient and NICU clinics. This is also driven by the rise of neonatal screening programs and parent's initiatives towards early detection.
   

Based on patient, the urine collection devices market is segmented as adult and pediatric. The adult segment dominated the market in 2024 accounting for USD 3.8 billion and is anticipated to grow at a CAGR of 6.4% during the forecast period.
 

• The growing elderly population worldwide has increased the prevalence of age-related conditions, including urinary incontinence, prostate disorders, and chronic kidney diseases.  According to the World Health Organization, the global population aged 60 years and above was 1.4 billion in 2021 and is expected to rise to 2.1 billion by 2024.
   
• The elderly demographic shift has also contributed to an increase in demand for certain medical supplies, apparatus, and medication. For example, the United Nations Department of Economic and Social Affairs reported that 2023 saw a rise in adult urine collection devices such as collection kits and specimen bags, with urinary incontinence rates hitting 10% and prostate disorders 15% among this age group.
   
• Additionally, decreases in hospital admissions and an overall reduced need for in-person medical support has driven prior reliance on such aids to further increase. With this, a growing preference for home care is being coupled with a rising demand for urine collection bags that offer greater ease-of-use, maintenance, comfort, and discreet utilization of such devices.
   
• The pediatric segment is expected to see the significant growth over the forecast period. Pediatric urine collection requires speed and skill sensitivity, as the process must be gentle, non-invasive, and skin-friendly. Owing to this, companies are designing pediatric urine bags and containers with non-allergenic stickers and soft material, and also incorporating fun designs to ease anxiety in children and encourage cooperation from parents.
   
• Accurate and sterile urine capture is critical to diagnose sepsis, dehydration, and other conditions in neonatal ICUs and pediatric departments. This promotes the utilization of urine collection bags for infants. This includes infant urine pouches that have secure adhesive seals and soft-fit contours, which support the growth of specialized urine collection bags for infants.
   
• Moreover, the addition of anti-reflux valves, clear volume markings, and tamper-proof seals to urine bags for children enhance their functionality and ensure sample integrity. These advances are particularly valuable in studies involving infants and toddlers where re-sampling presents challenges, thereby driving this segment's growth in the market.
   

Based on application, the urine collection devices market is segmented as clinical urinalysis, drug screening, pregnancy testing, and clinical research and studies. The clinical urinalysis is further segmented into urinary tract infections (UTI), kidney disorders, and other clinical urinalysis. The clinical urinalysis segment dominated the market in 2024 accounting for USD 2.1 billion and is anticipated to grow at a CAGR of 6.1% during the forecast period.
 

• The clinical urinalysis segment has the highest share in the market because urine samples are commonly used for diagnosing urinary tract infections (UTIs), kidney disorders, diabetes, and other metabolic or infectious diseases.
   
• Hospitals and diagnostic laboratories serve as the primary end users, relying on sterile and chemically stable collection devices to ensure accurate test results. This demand is further supported by the increasing frequency of routine checkups, rising prevalence of chronic conditions, and growing public awareness of early disease detection.
   
• Additionally, innovations in preservative-enabled containers and integrated transport systems are enhancing sample stability and laboratory efficiency, making clinical urinalysis a key application segment within the market.
   
• The drug screening segment holds the second position in the application segment and is anticipated to grow at a CAGR of 7.3% over the forecast period. The growth of this segment is attributed to the increased drug testing in the workplace, forensic examinations, anti-doping programs in athletics, and overall health-related activities. Urine tests are still the most common specimen collection method for drug testing because they are non-invasive and offer a wide detection period.
   
• Pregnancy testing segment was valued at USD 796.2 million in 2024 and is expected to grow at a CAGR of 6.7%. The growing accessibility of at-home pregnancy test kits and increasing awareness of early prenatal care are fueling demand.
   
• Clinical research & studies held the market share of 9.8% in 2024 and is anticipated to experience a steady growth in the coming years. The surge in decentralized clinical trials and emphasis on non-invasive sample collection are boosting adoption. Additionally, urine-based biomarkers are gaining traction for disease diagnostics and drug development.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the urine collection devices market is classified into hospitals, diagnostic laboratories, home care settings, and other end users. The hospitals segment dominated the market with a revenue share of 56.2% in 2024 owing to the increased utilization due to high patient turnover and diagnostic volume, growing need for sterile, single-use collection kits, and integration with electronic medical records (EMR) and lab systems, among others factors.
 

• The top three end use segments account for over 92% of the total market value, with hospitals as the highest segment due to the large volume of inpatient and outpatient diagnostic procedures, surgical monitoring and chronic disease management necessitating urine analysis. These facilities utilize varying levels of urine collection devices including specimen bags, collection kits, and containers for urinalysis, drug screening, pregnancy tests and monitoring post-operative processes.
   
• This is fueled by the rigorous control on infections, precision sample capture, and interfacing with EMR systems. Furthermore, the increasing hospital admissions among older patients and critically ill patients increases the demand for reliable urine collection systems, thereby expanding their use in clinical care pathways.
   
• The diagnostic laboratories segment has captured the second position in the end-use segment and is expected to grow at a CAGR of 7.1% during the forecast period. This growth is driven by the increasing demand for routine urinalysis, drug testing, infectious disease screening, and advanced genomic services.
   
• The steps these labs undertake to achieve the goals require sterile, leak-proof, and easy-to-transport urine collection devices that maintain sample stability and accuracy during testing. Increasing outpatient diagnostics, routine health check-ups, and the monitoring of chronic illnesses has surged demand for standardized urine collection kits and containers.
   
• The home care segment was valued at USD 586.4 million and is expected to witness a steady growth in the forecast period. This is driven by the rising elderly population managing chronic conditions at home and the growing adoption of telehealth. This increases demand for easy-to-use, hygienic urine collection kits that support remote diagnostics.

Looking for region specific data?

Download Free PDF

North America dominated the global urine collection devices market with the highest market share of 38.5% in 2024.
 

• The U.S. market was valued at USD 1.48 billion and USD 1.54 billion in 2021 and 2022, respectively. The market size reached USD 1.7 billion in 2024, growing from USD 1.6 billion in 2023 and is anticipated to grow at a CAGR of 6.1% between 2025 and 2034.
   
• The region has a well-established healthcare system with extensive access to diagnostic laboratories and large hospitals. According to the Centers for Disease Control and Prevention (CDC), clinical laboratory tests in the U.S. has increased by 12% between the years 2021 and 2023, reaching 14.2 billion tests annually.
   
• Similarly, the American Hospital Association reported in 2023 more than 6,100 hospitals with greater than 208 million laboratory tests for drug and pregnancy monitoring. Additionally, the Clinical Laboratory Management Association reported that the diagnostic laboratories performed roughly 45 million urinalysis tests in 2022 and are expecting an 8% growth in 2024.
   
• Moreover, new products, including pediatric urine specimen bags, kits, and leak-proof urine cups, are routinely launched on the market by U.S. manufacturers after receiving FDA clearances. As per FDA data, there was a jump in medical device approvals from 13 in 2021 to 17 in 2022 under the urine collection category.
   
• In addition, the FDA's Center for Devices and Radiological Health (CDRH) announced a 22% increase in the 2022 to 2023 period for approvals of new urological devices. This allows easy access for hospitals and laboratories that want to improve patient and operational workflows.
   
• The growing trend of focusing on-home care for elderly and post-operative patients in North America has also resulted in higher demand for self urine collection kits. Innovation coupled with remote monitoring tools is also contributing to increased growth in this market.
   

Europe urine collection devices market accounted for USD 1.3 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Europe remains a major market with a sophisticated diagnostic healthcare system, strong non-invasive testing acceptance, and growing utilizations of urine testing collection kits and specimen bags by hospitals, clinical laboratories, and geriatric centers.
   
• Western Europe and the Nordic countries have the highest consumption rates because of high healthcare expenditure and existing public health screening programs. Moreover, increasing elderly populations and growing chronic kidney and urinary tract infection diseases are sustaining the utilization of these devices in outpatient and inpatient settings.
   
• Further, the use of sterile, tamper-proof, and single-use urine collection systems is increasing due to strict infection control regulation in Europe. Sustainability concerns are also influential in product development strategy, leading to preference for lower PVC content and more recyclable materials used in urine collection bags and containers.
   
• Europe is expected to sustain its global leadership position for the next few years because the region continues to innovate in the devices for children and smart urine collection devices and their integration with other diagnostic systems. The segment is also increasing strongly due to expansion of remote patient monitoring and at-home tests in the post-COVID period.
   

The Asia Pacific urine collection devices market is anticipated to grow at the highest CAGR of 7.7% during the analysis timeframe.
 

• The expansion of the region is spurred by the enhanced healthcare system, growing awareness regarding preventive healthcare, and increased government spending on diagnostics. Countries like China, India, Japan, and South Korea are experiencing growing demand for urine collection kits in metropolitan hospitals and diagnostic centers.
   
• The rapid rise in lifestyle-related conditions like diabetes and kidney disorders, alongside other infectious diseases, is driving the need for routine urinalysis and urine testing, especially for infectious disease surveillance. These initiatives aim to promote uniformity and high standards in urine collection across both public and private healthcare institutions.
   
• Additionally, countries such as India, Thailand, and Malaysia are leading in the medical tourism industry which is further fueling the market for urine collection systems for diagnostics to be used in preventive medicine and during surgeries. Countries like India and Indonesia are also championing the pediatric demand for urine collection systems which are slowly being integrated into outpatient and daycare services.
   
• There is an increase in the number of local companies offering low-cost alternatives as well as international companies pursuing entry through mergers and joint ventures. The Asia Pacific region stands out for growth prospects in both value and innovation due to the ongoing digital transformation of medicine and the introduction of remote testing in rural and semi-urban regions.
   

The Latin America urine collection devices market is experiencing robust growth over the analysis timeframe.
 

• Latin America growth is fueled by increasing investment in public healthcare systems and rising awareness of preventive diagnostics across countries like Brazil, Mexico, and Argentina.
   
• The expansion of universal healthcare coverage is enhancing the routine testing of urine specimens for urinary tract infections, diabetes, and kidney diseases. Though the public sector continues to dominate the market for urine specimen bags and collection kits, there is a shift among private diagnostic laboratories toward the use of better quality and sterile plastic.
   
• Further, the region faces significant inequities in healthcare access for rural patients, which necessitates the development of portable and simple urine collection devices that can be used in out-of-the-way locations. There is also targeted demand for community health promotion and advocacy for maternal and child health for specialized urine collection devices used in public health campaigns.
   

Urine Collection Devices Market Share

• global market presents a competitive in nature landscape, characterized by the presence of both global leaders and numerous regional players. Key players such as Becton, Dickinson and Company, Thermo Fisher Scientific, Medline, Roche, and Abbott collectively accounts for 43% of the total market share, leveraging their strong product portfolios, global distribution networks, and focus on diagnostic integration. These companies dominate high-volume procurement channels, especially in hospitals and diagnostic laboratories, and continue to invest in innovation to align with evolving clinical needs such as molecular testing and liquid biopsy compatibility.
   

Beyond these market leaders, the landscape features a broad spectrum of mid-sized and regional companies like Aspen Surgical, Angiplast, Polymed, and Ardo Medical. These players cater to specific end-user demands including pediatric care, home-based urine collection, and low-cost offerings for resource-constrained markets. Their competitive strength often lies in localized manufacturing, flexible pricing strategies, and rapid adaptability to regional healthcare protocols. With growing demand for user-friendly, disposable, and eco-conscious collection systems, many of these companies are expanding their presence through distribution partnerships and product customization.
 

The market is further shaped by technological advancements and strategic initiatives such as mergers, acquisitions, and product line expansions. Companies are focusing on developing smart urine collection devices with sensor integration, anti-contamination designs, and improved patient comfort to differentiate themselves in a crowded field. As healthcare systems globally place more emphasis on infection control, home care diagnostics, and early disease detection, competition is expected to intensify, particularly in high-growth regions like Asia Pacific and Latin America.
 

Urine Collection Devices Market Companies

Few of the prominent players operating in the urine collection devices industry include:

• Abbott
• ANGIPLAST
• Ardo Medical
• Aspen Surgical 
• Becton, Dickinson and Company
• BioTouch
• Cardinal Health
• convatec
• HENSO
• Labcorp (Litholink)
• MEDLINE
• POLYMED
• QIAGEN
• Roche
• Thermo Fisher Scientific
   
• Becton, Dickinson and Company (BD)

BD offers a comprehensive range of urine collection systems, including the BD Vacutainer line, which is widely trusted for diagnostic accuracy and sample integrity. Its strong hospital presence and integration with laboratory automation platforms make it a preferred partner for clinical labs and health systems.
 

• Thermo Fisher Scientific

Thermo Fisher stands out with advanced urine collection kits optimized for molecular and genomic testing applications. Its innovation-driven portfolio and compatibility with downstream diagnostic workflows give it a strategic edge in high-growth areas like liquid biopsy and precision medicine.
 

• Medline Industries

Medline differentiates itself through cost-effective, high-quality urine specimen bags and accessories, with a strong focus on infection control and patient comfort. Its robust distribution network and strong presence in long-term care and home healthcare settings enhance its market reach.
 

Urine Collection Devices Industry News:

• In September 2024, PreAnalytiX GmbH, a joint venture between QIAGEN and BD, announced the launch of the PAXgene Urine Liquid Biopsy Set for reliable analysis of cell-free DNA (cfDNA) from urine using qPCR, digital PCR, and NGS. The product was commercialized by QIAGEN. This launch strengthened both companies presence in the urine collection devices market by addressing the rising demand for non-invasive, genomic-based diagnostics. It also expanded the clinical utility of urine samples in precision medicine applications.
   
• In July 2022, The University of Alabama at Birmingham and Children’s of Alabama, in collaboration with local entrepreneurs, launched Zorro-Flow Inc., a startup emerging from the UAB Harbert Institute for Innovation and Entrepreneurship. The company developed a neonatal external urine-collection device designed to safely and effectively collect urine in critically ill female neonates and infants under one year of age. This innovation addressed a critical gap in pediatric urine collection, particularly for vulnerable patient groups, and expanded the market for specialized, age-specific urine collection solutions.
   
• In October 2022, Greiner Bio-One launched the Urine Cup with Integrated Transfer Device to enable safe and hygienic urine sample collection and transfer. The device minimizes contamination risk and is compatible with vacuum urine tubes for a closed, efficient system. This innovation enhanced accuracy in clinical workflows and strengthened Greiner Bio-One’s position in the market.
   

The urine collection devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Urine collection kits
• Urine specimen bags
• Urine cups and containers

Market, By Patient

• Adult
• Pediatric

Market, By Application

• Clinical urinalysis
  • Urinary tract infections (UTI)
  • Kidney disorders
  • Other clinical urinalysis
• Drug screening
• Pregnancy testing
• Clinical research and studies

Market, By End Use

• Hospitals
• Diagnostic laboratories
• Home care settings
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE